Back to CITADEL ADVISORS LLC CITADEL ADVISORS LLC

SMTISMTI
Showing 8 of 19 quarters

Position history for CITADEL ADVISORS LLCCITADEL ADVISORS LLC's holdings in SANARA MEDTECH INC

Yes. Citadel Advisors holds 36,813 shares of SMTI (Sanara Medtech), worth $868,419, as of its Q2 2026 13F filing. It increased the position by 5,700 shares (+18.3%) from Q1 2026. Citadel Advisors has held SMTI since Q3 2024, across 8 quarterly 13F filings.

Current Value

$868,419

Current Shares

36,813

Total Value Change

+$248,711

Total Shares Change

+16,320

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
36,813
+18.3%
$868,4190.0%$23.59
29
2026-Q1
Increased
31,113
+206.6%
$534,5210.0%$17.18
39
2025-Q4
Decreased
10,148
-46.7%
$236,9560.0%$23.35
0
2025-Q3
Decreased
19,054
-16.3%
$604,5830.0%$31.73
0
2025-Q2
Increased
22,773
+47.7%
$646,5260.0%$28.39
34
2025-Q1
Decreased
15,423
-29.8%
$476,1080.0%$30.87
0
2024-Q4
Increased
21,984
+7.3%
$729,8690.0%$33.20
26
2024-Q3
New
20,493
-
$619,7080.0%$30.24
34

Other major holders of SMTI: Baird Financial Group, Inc., BlackRock Finance, Inc., BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used